Phase
Condition
Vitiligo
Treatment
5-Fluorouracil plain powder
a new effervescent mixture 5-florouracil formula
Clinical Study ID
Ages 10-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients who will be diagnosed as localized stable vitiligo.
Age older than 10 years
Stability of lesions for a duration of at least 1 year.
Patients who didn't receive treatment for vitiligo in the previous 6 weeks beforestarting the study.
Patients who agreed to join the study and signed written consent and continued tillthe end of the follow up period
Exclusion
Exclusion Criteria:
Patients with vitiligo patches on mucous membrane,
Patients with Koebner phenomenon,
Other uncontrolled systemic illnesses
Patients receiving any systemic or topical treatment for vitiligo
Study Design
Connect with a study center
Facualty of Pharmacy, Al Azhar University
Cairo, 11765
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.